Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Letters to the Editor

Serological Responses to Cryptosporidium Infection

T. B. Muller, F. J. Frost, G. F. Craun, R. L. Calderon
T. B. Muller
Lovelace Clinic Foundation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. J. Frost
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. F. Craun
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. L. Calderon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.69.3.1974-1975.2001
  • Article
  • Info & Metrics
  • PDF
Loading

Dann et al. (1) tested immune responses of volunteers exposed to Cryptosporidium oocysts using an enzyme-linked immunosorbent assay (ELISA). They found fecal immunoglobulin A (IgA) but no serum IgG2 response to infection. They concluded that in the naive individual, the parasite elicits a strong secretory antibody response but fails to provide adequate immune stimulation for serum antibody detectable by ELISA.

Since prior research indicates the ELISA, using unpurified antigen, may lack the sensitivity to detect a serological response to infection (2-4), we believe this conclusion is misleading. The implied conclusion that these infected volunteers did not respond contradicts findings of another study of the same volunteer group (5). Moss et al., using a Western blot assay, found a characteristic antibody response to either 15/17- or 27-kDa markers following infection in 10 of the 11 volunteers who experienced symptomatic illness (5). The Moss study also found serological response to Cryptosporidium antigens at day 0 in 21 of 29 volunteers (5), contradicting the assumptions of the Dann study that volunteers were immunologically naive at baseline. Volunteers immunologically naive by Western blotting excreted a higher number of oocysts following infection (5).

We tracked serological responses to infection, using a previously described Western blot assay (3), for one laboratory worker accidentally infected with C. parvum. During the 1.5 years prior to the accidental oocyst exposure, the worker had no IgA or IgM serological response to either the 15/17- or 27-kDa marker and no IgG response to the 15/17-kDa marker. He had a very weak IgG response to the 27-kDa marker that was only periodically detectable. He would, therefore, be classified as immunologically naive by Western blotting (5). Classical cryptosporidiosis developed 10 days following the exposure and 4 weeks later he developed an intense IgA, IgM, and IgG response to both the 15/17- and 27-kDa markers. The IgG and IgM responses peaked at 4 weeks postinfection and declined rapidly. IgM reached low levels by 22 weeks postinfection while IgA remained significantly elevated at 42 weeks postinfection. The IgG response peaked at 14 weeks postinfection. Response to the 15/17-kDa marker declined to near background by 42 weeks postinfection whereas response to the 27-kDa marker remained elevated at 71 weeks postinfection. If infection in immunologically naive individuals fails to provide adequate immune stimulation for serum antibody to develop, as suggested by Dann et al. (1), we should not have observed these classical serum antibody responses to infection.

Because of the large number of antigens contained in an oocyst, any assay based on aggregate serological responses to all of these antigens may be less sensitive than an assay, such as Western blotting, that examines responses to Cryptosporidium-specific antigens (2-4). Given published concerns with the ELISA, the failure of the authors to cite Western blot results for the same volunteers is puzzling. Their ELISA was clearly better able to detect secretory than serum responses to infection. This may have occurred either because the response was stronger or because of less cross-reacting secretory antibody.

This issue should not detract from the important and other supported findings of the study. Improved methods to detect infection may help better understand the epidemiology of Cryptosporidium infection.

  • Copyright © 2001 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Dann S. M.,
    2. Okhuysen P. C.,
    3. Salameh B. M.,
    4. DuPont H. L.,
    5. Chappell C. L.
    Fecal antibodies to Cryptosporidium parvum in healthy volunteers.Infect. Immun.68200050685074
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Frost, F. J., and G. F. Craun. Serological response to human Cryptosporidium infection. (Letter.) Infect Immun. 66:4008.
  3. 3.↵
    1. Frost F. J.,
    2. de la Cruz A. A.,
    3. Moss D. M.,
    4. Curry M.,
    5. Calderon R. L.
    Comparisons of ELISA and Western blot assays for detection of Cryptosporidium antibody.Epidemiol. Infect.1211998205211
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Moss D. M.,
    2. Bennett S. N.,
    3. Arrowood M. J.,
    4. Hurd M. R.,
    5. Wahlquist S. P.,
    6. Lammie P. J.
    Enzyme-linked immunoelectrotransfer blot analysis of a cryptosporidiosis outbreak on a US Coast Guard cutter.Am. J. Trop. Med. Hyg.581994110118
    OpenUrl
  5. 5.↵
    1. Moss D. M.,
    2. Chappell C. L.,
    3. Okhuysen P. C.,
    4. Okhuysen P. C.,
    5. DuPoint H. L.,
    6. Arrowood M. J.,
    7. Hightower A. W.,
    8. Lammie P. J.
    The antibody response to 27-, 17-, and 15-Kda Cryptosporidium antigens following experimental infection in humans.J. Infect. Dis.1781998827833
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.
    1. Okhuysen P. C.,
    2. Chappel C. L.,
    3. Sterling C. R.,
    4. Jakubowski W.,
    5. DuPont H. L.
    Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum.Infect. Immun.661998441443
    OpenUrlAbstract/FREE Full Text

AUTHORS’ REPLY

AUTHORS' REPLY

Muller et al. have suggested that the serum enzyme-linked immunosorbent assay (ELISA) results referred to in our recent publications are misleading and may have failed to detect an antibody response that can only be revealed with the immunoblot assay (1-2). We have responded to this issue previously and have attempted to clarify our position (1-5).

The ELISA method used in our experiments was adopted since it was (and continues to be) a standard by which Crypto

sporidium prevalence is measured. The prevalence results of our screening assays (i.e., prior to challenge) are consistent with serological assays done in the United States (1-3, 1-7) and other countries (1-4, 1-6), suggesting that our technique is no less sensitive. Perhaps more importantly, we have shown that prechallenge ELISA results correlate well with the relative resistance of individuals to subsequent challenge (1-1). Lastly, the ELISA method in our hands is sufficiently sensitive to identify immunoglobulin A (IgA) reactivity in samples containing as little as 2 ng of total IgA.

The sensitivity and specificity of any assay system are complicated, especially in those instances where antigen preparations are complex (and potentially cross-reactive) and where there is no defined negative population. Both of these problems face those working withCryptosporidium serological studies, regardless of the assay format (immunoblot or ELISA) in use. To further complicate the picture,Cryptosporidium oocysts are purified from fecal material. Thus, the degree of purity can affect results since bacteria and yeast antigens may be included to various extents in the assay and complicate interpretation. Further, there may be lot-to-lot variability in the antigen preparation, especially if the antigen preparations are obtained from different facilities or stored under various conditions. These problems will be lessened when a defined, purified antigen, such as a recombinant or peptide fragment, can be identified. However, this uniform preparation will have to exhibit the desired sensitivity and specificity before it can be generally adopted for serological studies. Further, such an antigen must represent a protein that is immunogenic and found in all Cryptosporidiumspecies that are capable of infecting humans. When such a system is developed and adopted as the standard, direct comparison of results from different studies will be possible.

These and other issues surrounding the accurate measurement of the antibody response will be illuminated by careful, scientific studies using defined assay systems. We are currently examining the fecal IgA response to recombinant antigens of sporozoite surface proteins and immunogenic components of the oocyst. Further, immunoblot assays of fecal IgA are in progress and will provide evidence for the specific antigens recognized at the mucosal site of the infection.

  • Copyright © 2001 American Society for Microbiology

REFERENCES

  1. 1-1.↵
    1. Chappell C. L.,
    2. Okhuysen P. C.,
    3. Sterling C. R.,
    4. Wang C.,
    5. Jakubowski W.
    Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G. Am. J. Trop. Med. Hyg. 60 1999 157 164
    OpenUrlAbstract
  2. 1-2.↵
    1. Dann S. M.,
    2. Okhuysen P. C.,
    3. Salameh B. M.,
    4. DuPont H. L.,
    5. Chappell C. L.
    Fecal antibodies to Cryptosporidium parvum in healthy volunteers. Infect. Immun. 68 2000 5068 5074
    OpenUrlAbstract/FREE Full Text
  3. 1-3.↵
    1. Hayes E. B.,
    2. Matte T. D.,
    3. O'Brien T. R.,
    4. McKinely T. W.,
    5. Logsdon G. S.,
    6. Rose J. B.,
    7. Ungar B. L. P.,
    8. Word D. M.,
    9. Pinsky P. F.,
    10. Cummings M. L.,
    11. Wilson M. A.,
    12. Long E. G.,
    13. Hurwitz E. S.,
    14. Juranek D. D.
    Large community outbreak of cryptosporidiosis due to contamination of a filtered public water supply. N. Eng. J. Med. 320 1989 1372 1376
    OpenUrlCrossRefPubMedWeb of Science
  4. 1-4.↵
    1. Miron D.,
    2. Colodner R.,
    3. Kenes Y.
    Age-related seroprevalence of Cryptosporidium in northern Israel. Israel Med. Assoc. J. 2 2000 343 345
    OpenUrlPubMedWeb of Science
  5. 1-5.↵
    1. Okhuysen P. C.,
    2. Chappell C. L.,
    3. DuPont H. L.,
    4. Sterling C. R.,
    5. Jakubowski W.
    Serological response to human Cryptosporidium infections. (Letter.) Infect. Immun. 66 1998 4008 4009
    OpenUrlFREE Full Text
  6. 1-6.↵
    1. Petry F.
    Epidemiological study of Cryptosporidium parvum antibodies in sera of persons from Germany. Infection 26 1998 7 10
    OpenUrlPubMed
  7. 1-7.↵
    1. Ungar B. L. P.,
    2. Mulligan M.,
    3. Nutman T. B.
    Serological evidence of Cryptosporidium infection in U.S. volunteers before and during Peace Corps service in Africa. Arch. Intern. Med. 149 1989 894 897
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Serological Responses to Cryptosporidium Infection
T. B. Muller, F. J. Frost, G. F. Craun, R. L. Calderon
Infection and Immunity Mar 2001, 69 (3) 1974-1975; DOI: 10.1128/IAI.69.3.1974-1975.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Serological Responses to Cryptosporidium Infection
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Serological Responses to Cryptosporidium Infection
T. B. Muller, F. J. Frost, G. F. Craun, R. L. Calderon
Infection and Immunity Mar 2001, 69 (3) 1974-1975; DOI: 10.1128/IAI.69.3.1974-1975.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • REFERENCES
    • AUTHORS' REPLY
    • REFERENCES
  • Info & Metrics
  • PDF

KEYWORDS

Antibodies, Protozoan
cryptosporidiosis

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522